Document is current
Any future updates will be listed below
-
Authors
Junaković, Anamari
Skočić Hanžek, Milena
Adamec, Ivan
Krbot Skorić, Magdalena
Habek, Mario https://orcid.org/0000-0002-3360-1748
- License Information
-
More Information
Article History
Received: 11 December 2022
Accepted: 27 March 2023
First Online: 4 April 2023
Declarations
:
: The study protocol was approved by the ethical committees of the University Hospital Center Zagreb and the University of Zagreb, School of Medicine (class: 8.1-19/74-2; number: 02/21 AG).
: AJ: nothing to disclose.MSH: nothing to disclose.IA: participated as a clinical investigator and/or received consultation and/or speaker fees from Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, and TG Pharmaceuticals.MKS: received consultation and/or speaker fees from Sanofi Genzyme and Roche.MH: participated as a clinical investigator and/or received consultation and/or speaker fees from Biogen, Sanofi Genzyme, Merck, Bayer, Novartis, Pliva/Teva, Roche, Alvogen, Actelion, Alexion Pharmaceuticals, and TG Pharmaceuticals.
